RU2409575C2 - ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ, КОТОРЫЕ МОЖНО ИСПОЛЬЗОВАТЬ В КАЧЕСТВЕ ИНГИБИТОРОВ ПЕПТИДДЕФОРМИЛАЗЫ (ПДФ) - Google Patents
ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ, КОТОРЫЕ МОЖНО ИСПОЛЬЗОВАТЬ В КАЧЕСТВЕ ИНГИБИТОРОВ ПЕПТИДДЕФОРМИЛАЗЫ (ПДФ) Download PDFInfo
- Publication number
- RU2409575C2 RU2409575C2 RU2007143501/04A RU2007143501A RU2409575C2 RU 2409575 C2 RU2409575 C2 RU 2409575C2 RU 2007143501/04 A RU2007143501/04 A RU 2007143501/04A RU 2007143501 A RU2007143501 A RU 2007143501A RU 2409575 C2 RU2409575 C2 RU 2409575C2
- Authority
- RU
- Russia
- Prior art keywords
- ylamino
- pyridin
- hydroxyacetamide
- group
- radical
- Prior art date
Links
- 150000005234 imidazo[1,2-a]pyridines Chemical class 0.000 title abstract 2
- 239000000081 peptide deformylase inhibitor Substances 0.000 title description 4
- -1 (C1-C12)alkyl radical Chemical class 0.000 claims abstract description 209
- 150000001875 compounds Chemical class 0.000 claims abstract description 40
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 19
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 19
- 125000003118 aryl group Chemical group 0.000 claims abstract description 18
- 150000003254 radicals Chemical class 0.000 claims abstract description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 12
- 108010026809 Peptide deformylase Proteins 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 125000005843 halogen group Chemical group 0.000 claims abstract description 9
- 125000003277 amino group Chemical group 0.000 claims abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 4
- 239000012453 solvate Substances 0.000 claims abstract description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 3
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims abstract 5
- 230000002401 inhibitory effect Effects 0.000 claims abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 20
- 229910052801 chlorine Inorganic materials 0.000 claims description 19
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 7
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 102000005741 Metalloproteases Human genes 0.000 claims description 3
- 108010006035 Metalloproteases Proteins 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 2
- 150000004677 hydrates Chemical class 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 229910052721 tungsten Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 description 26
- 229960001171 acetohydroxamic acid Drugs 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 125000000753 cycloalkyl group Chemical group 0.000 description 17
- 125000003342 alkenyl group Chemical group 0.000 description 14
- 125000000304 alkynyl group Chemical group 0.000 description 14
- 125000004404 heteroalkyl group Chemical group 0.000 description 14
- 125000000217 alkyl group Chemical group 0.000 description 13
- 125000001072 heteroaryl group Chemical group 0.000 description 12
- 239000001301 oxygen Substances 0.000 description 12
- 125000003710 aryl alkyl group Chemical group 0.000 description 10
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 10
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 8
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 description 8
- 229910052731 fluorine Inorganic materials 0.000 description 8
- 239000011593 sulfur Substances 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 125000006413 ring segment Chemical group 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 239000010703 silicon Substances 0.000 description 4
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 4
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 description 1
- KEIFWROAQVVDBN-UHFFFAOYSA-N 1,2-dihydronaphthalene Chemical compound C1=CC=C2C=CCCC2=C1 KEIFWROAQVVDBN-UHFFFAOYSA-N 0.000 description 1
- MMZYCBHLNZVROM-UHFFFAOYSA-N 1-fluoro-2-methylbenzene Chemical compound CC1=CC=CC=C1F MMZYCBHLNZVROM-UHFFFAOYSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- NGQOAUHFTUPGAE-UHFFFAOYSA-N 2-[(1-benzylimidazo[1,2-a]quinolin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C1=CC=CC=C1C=C2)NCC(=O)NO NGQOAUHFTUPGAE-UHFFFAOYSA-N 0.000 description 1
- NLACBTLSTHXYMB-UHFFFAOYSA-N 2-[(1-butylimidazo[1,2-a]quinolin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C1=CC=CC=C1C=C2)NCC(=O)NO NLACBTLSTHXYMB-UHFFFAOYSA-N 0.000 description 1
- WUEPPYHHIXBXBQ-UHFFFAOYSA-N 2-[(1-tert-butylimidazo[1,2-a]quinolin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)(C)(C)C1=C(N=C2N1C1=CC=CC=C1C=C2)NCC(=O)NO WUEPPYHHIXBXBQ-UHFFFAOYSA-N 0.000 description 1
- TWHLPUGHCSOBFB-UHFFFAOYSA-N 2-[(3,5-diethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)C1=C(N=C2N1C(=CC=C2)CC)NCC(=O)NO TWHLPUGHCSOBFB-UHFFFAOYSA-N 0.000 description 1
- NZCBPGIZCOHCJX-UHFFFAOYSA-N 2-[(3,5-dipropylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CC)C1=C(N=C2N1C(=CC=C2)CCC)NCC(=O)NO NZCBPGIZCOHCJX-UHFFFAOYSA-N 0.000 description 1
- YWJVRMLHXOJAEB-UHFFFAOYSA-N 2-[(3-benzyl-6,8-dibromo-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C(=C(C=C2Br)Br)C)NCC(=O)NO YWJVRMLHXOJAEB-UHFFFAOYSA-N 0.000 description 1
- FXKGHTXXASOTFA-UHFFFAOYSA-N 2-[(3-benzyl-6,8-dibromoimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C=C(C=C2Br)Br)NCC(=O)NO FXKGHTXXASOTFA-UHFFFAOYSA-N 0.000 description 1
- OQIBLMNYIBFEIH-UHFFFAOYSA-N 2-[(3-benzyl-6-bromo-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C(=C(C=C2)Br)C)NCC(=O)NO OQIBLMNYIBFEIH-UHFFFAOYSA-N 0.000 description 1
- QQMNVYBEDQRSEU-UHFFFAOYSA-N 2-[(3-benzyl-6-nitroimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C=C(C=C2)[N+](=O)[O-])NCC(=O)NO QQMNVYBEDQRSEU-UHFFFAOYSA-N 0.000 description 1
- BQUVKACMUREQGT-UHFFFAOYSA-N 2-[(3-benzyl-7-ethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C=CC(=C2)CC)NCC(=O)NO BQUVKACMUREQGT-UHFFFAOYSA-N 0.000 description 1
- GIPYEMZQYJTZNK-UHFFFAOYSA-N 2-[(3-benzyl-8-hydroxyimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C=CC=C2O)NCC(=O)NO GIPYEMZQYJTZNK-UHFFFAOYSA-N 0.000 description 1
- YIYNULHLQOJHMP-UHFFFAOYSA-N 2-[(3-benzylimidazo[2,1-a]isoquinolin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C=CC1=CC=CC=C21)NCC(=O)NO YIYNULHLQOJHMP-UHFFFAOYSA-N 0.000 description 1
- BRNLPUOOYAPOTN-UHFFFAOYSA-N 2-[(3-butyl-5-chloroimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C(=CC=C2)Cl)NCC(=O)NO BRNLPUOOYAPOTN-UHFFFAOYSA-N 0.000 description 1
- GZEWQFLJQCANRH-UHFFFAOYSA-N 2-[(3-butyl-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C(=CC=C2)C)NCC(=O)NO GZEWQFLJQCANRH-UHFFFAOYSA-N 0.000 description 1
- IWTKJRGFYNJCJU-UHFFFAOYSA-N 2-[(3-butyl-5-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C(=CC=C2)CCC)NCC(=O)NO IWTKJRGFYNJCJU-UHFFFAOYSA-N 0.000 description 1
- XANRFBWHSKOMRU-UHFFFAOYSA-N 2-[(3-butyl-6-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C=C(C=C2)C)NCC(=O)NO XANRFBWHSKOMRU-UHFFFAOYSA-N 0.000 description 1
- CAVUTILRWWLNOB-UHFFFAOYSA-N 2-[(3-butyl-6-nitroimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C=C(C=C2)[N+](=O)[O-])NCC(=O)NO CAVUTILRWWLNOB-UHFFFAOYSA-N 0.000 description 1
- AZMVTPWKTNQRBV-UHFFFAOYSA-N 2-[(3-butyl-7-ethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C=CC(=C2)CC)NCC(=O)NO AZMVTPWKTNQRBV-UHFFFAOYSA-N 0.000 description 1
- OPVLONGMUBSVQW-UHFFFAOYSA-N 2-[(3-butyl-8-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C=CC=C2C)NCC(=O)NO OPVLONGMUBSVQW-UHFFFAOYSA-N 0.000 description 1
- SUZYVMBUXGLILJ-UHFFFAOYSA-N 2-[(3-butylimidazo[2,1-a]isoquinolin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(CCC)C1=C(N=C2N1C=CC1=CC=CC=C21)NCC(=O)NO SUZYVMBUXGLILJ-UHFFFAOYSA-N 0.000 description 1
- CWGGJUDVJFEAEY-UHFFFAOYSA-N 2-[(3-cyclohexyl-8-hydroxyimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C1(CCCCC1)C1=C(N=C2N1C=CC=C2O)NCC(=O)NO CWGGJUDVJFEAEY-UHFFFAOYSA-N 0.000 description 1
- JHLJXBSANQEYAT-UHFFFAOYSA-N 2-[(3-cyclohexylimidazo[2,1-a]isoquinolin-2-yl)amino]-N-hydroxyacetamide Chemical compound C1(CCCCC1)C1=C(N=C2N1C=CC1=CC=CC=C21)NCC(=O)NO JHLJXBSANQEYAT-UHFFFAOYSA-N 0.000 description 1
- IHJFROXFFZVUKO-UHFFFAOYSA-N 2-[(3-ethyl-5-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)C1=C(N=C2N1C(=CC=C2)CCC)NCC(=O)NO IHJFROXFFZVUKO-UHFFFAOYSA-N 0.000 description 1
- FQHGJXXSIVTLCW-UHFFFAOYSA-N 2-[(5-amino-3-butylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCCC FQHGJXXSIVTLCW-UHFFFAOYSA-N 0.000 description 1
- JJZSNMLSUSUSDZ-UHFFFAOYSA-N 2-[(5-amino-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCCCC JJZSNMLSUSUSDZ-UHFFFAOYSA-N 0.000 description 1
- PXKMKJVFRRJNMX-UHFFFAOYSA-N 2-[(5-bromo-3-butylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCCC PXKMKJVFRRJNMX-UHFFFAOYSA-N 0.000 description 1
- NZGKPCKQYGCPRH-UHFFFAOYSA-N 2-[(5-bromo-3-ethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CC NZGKPCKQYGCPRH-UHFFFAOYSA-N 0.000 description 1
- CEDIQFVEVOXEEX-UHFFFAOYSA-N 2-[(5-bromo-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCCCC CEDIQFVEVOXEEX-UHFFFAOYSA-N 0.000 description 1
- BSYYLXXHUQGALW-UHFFFAOYSA-N 2-[(5-chloro-3-ethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound ClC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CC BSYYLXXHUQGALW-UHFFFAOYSA-N 0.000 description 1
- HHSPXVHAIGOARG-UHFFFAOYSA-N 2-[(5-chloro-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound ClC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCCCC HHSPXVHAIGOARG-UHFFFAOYSA-N 0.000 description 1
- SSBSQUVCTCQKKY-UHFFFAOYSA-N 2-[(5-chloro-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound ClC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCC SSBSQUVCTCQKKY-UHFFFAOYSA-N 0.000 description 1
- MVBXAVDFVIXRTB-UHFFFAOYSA-N 2-[(5-ethyl-3-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)C MVBXAVDFVIXRTB-UHFFFAOYSA-N 0.000 description 1
- WCCZRBJMVWXKLN-UHFFFAOYSA-N 2-[(5-ethyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCCCC WCCZRBJMVWXKLN-UHFFFAOYSA-N 0.000 description 1
- WMZTYUOEUJDHKL-UHFFFAOYSA-N 2-[(5-ethyl-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCC WMZTYUOEUJDHKL-UHFFFAOYSA-N 0.000 description 1
- CNHPOPPGVHVPIE-UHFFFAOYSA-N 2-[(6,8-dibromo-3-butyl-5,7-dimethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C(=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CCCC)Br)C CNHPOPPGVHVPIE-UHFFFAOYSA-N 0.000 description 1
- ZLSCXQXAFGBWOG-UHFFFAOYSA-N 2-[(6,8-dibromo-3-butyl-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CCCC)Br ZLSCXQXAFGBWOG-UHFFFAOYSA-N 0.000 description 1
- NSHHSAJYYGIXQI-UHFFFAOYSA-N 2-[(6,8-dibromo-3-ethyl-5,7-dimethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C(=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CC)Br)C NSHHSAJYYGIXQI-UHFFFAOYSA-N 0.000 description 1
- KASALMDWONQSRR-UHFFFAOYSA-N 2-[(6,8-dibromo-3-ethyl-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CC)Br KASALMDWONQSRR-UHFFFAOYSA-N 0.000 description 1
- UYCJPQDXDCTPIR-UHFFFAOYSA-N 2-[(6,8-dibromo-5,7-dimethyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C(=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CCCCC)Br)C UYCJPQDXDCTPIR-UHFFFAOYSA-N 0.000 description 1
- ZRPJATTVGFFARP-UHFFFAOYSA-N 2-[(6,8-dibromo-5-methyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CCCCC)Br ZRPJATTVGFFARP-UHFFFAOYSA-N 0.000 description 1
- QBCAMCPGYBRNAO-UHFFFAOYSA-N 2-[(6,8-dibromo-5-methyl-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CCC)Br QBCAMCPGYBRNAO-UHFFFAOYSA-N 0.000 description 1
- DJOQAJRGOURHDT-UHFFFAOYSA-N 2-[(6-amino-3-benzylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC1=CC=CC=C1 DJOQAJRGOURHDT-UHFFFAOYSA-N 0.000 description 1
- SCRAJJICDFPLSO-UHFFFAOYSA-N 2-[(6-amino-3-butylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CCCC SCRAJJICDFPLSO-UHFFFAOYSA-N 0.000 description 1
- OIFWTXZJSYDEKK-UHFFFAOYSA-N 2-[(6-amino-3-ethylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC OIFWTXZJSYDEKK-UHFFFAOYSA-N 0.000 description 1
- NQOKRGFILVTISN-UHFFFAOYSA-N 2-[(6-bromo-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CCCCC NQOKRGFILVTISN-UHFFFAOYSA-N 0.000 description 1
- MXWHEWZRPWUSHP-UHFFFAOYSA-N 2-[(6-bromo-3-tert-butyl-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=CC=2N(C=1C)C(=C(N=2)NCC(=O)NO)C(C)(C)C MXWHEWZRPWUSHP-UHFFFAOYSA-N 0.000 description 1
- PDYOYGMZYLWDJJ-UHFFFAOYSA-N 2-[(6-bromo-3-tert-butyl-5-methylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxypropanamide Chemical compound BrC=1C=CC=2N(C=1C)C(=C(N=2)NC(C(=O)NO)C)C(C)(C)C PDYOYGMZYLWDJJ-UHFFFAOYSA-N 0.000 description 1
- IQQDYMSEWRKXMU-UHFFFAOYSA-N 2-[(6-bromo-5-methyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound CCCCCc1c(NCC(=O)NO)nc2ccc(Br)c(C)n12 IQQDYMSEWRKXMU-UHFFFAOYSA-N 0.000 description 1
- GDAXCANJODXHFE-UHFFFAOYSA-N 2-[(6-bromo-5-methyl-3-propan-2-ylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=CC=2N(C=1C)C(=C(N=2)NCC(=O)NO)C(C)C GDAXCANJODXHFE-UHFFFAOYSA-N 0.000 description 1
- JDXRNAYIFMCPRY-UHFFFAOYSA-N 2-[(6-bromo-5-methyl-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=CC=2N(C=1C)C(=C(N=2)NCC(=O)NO)CCC JDXRNAYIFMCPRY-UHFFFAOYSA-N 0.000 description 1
- OAKDNVHIIZRUIH-UHFFFAOYSA-N 2-[(6-bromo-5-methyl-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxypropanamide Chemical compound BrC=1C=CC=2N(C=1C)C(=C(N=2)NC(C(=O)NO)C)CCC OAKDNVHIIZRUIH-UHFFFAOYSA-N 0.000 description 1
- QNKNIQXCTZYVCO-UHFFFAOYSA-N 2-[(6-bromo-7,8-dimethyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C(=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CCCCC)C)C QNKNIQXCTZYVCO-UHFFFAOYSA-N 0.000 description 1
- YLFLOFHTGRKUOB-UHFFFAOYSA-N 2-[(6-bromo-8-methyl-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxypropanamide Chemical compound BrC=1C=C(C=2N(C=1)C(=C(N=2)NC(C(=O)NO)C)CCC)C YLFLOFHTGRKUOB-UHFFFAOYSA-N 0.000 description 1
- QRCLISOSGZKUJL-UHFFFAOYSA-N 2-[(6-chloro-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound ClC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CCCCC QRCLISOSGZKUJL-UHFFFAOYSA-N 0.000 description 1
- NEFVGIIJDUZSII-UHFFFAOYSA-N 2-[(6-chloro-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxypropanamide Chemical compound ClC=1C=CC=2N(C=1)C(=C(N=2)NC(C(=O)NO)C)CCC NEFVGIIJDUZSII-UHFFFAOYSA-N 0.000 description 1
- JDNGTVPLLSITOX-UHFFFAOYSA-N 2-[(6-fluoro-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound FC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CCCCC JDNGTVPLLSITOX-UHFFFAOYSA-N 0.000 description 1
- PEZNDDZRCAWJRP-UHFFFAOYSA-N 2-[(6-fluoroimidazo[1,2-a]pyridin-2-yl)amino]-n-hydroxyacetamide Chemical compound C1=C(F)C=CC2=NC(NCC(=O)NO)=CN21 PEZNDDZRCAWJRP-UHFFFAOYSA-N 0.000 description 1
- WQOCFAGXJUXZPY-UHFFFAOYSA-N 2-[(7-ethyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=2N(C=C1)C(=C(N=2)NCC(=O)NO)CCCCC WQOCFAGXJUXZPY-UHFFFAOYSA-N 0.000 description 1
- VWMIHRBIXYAHLA-UHFFFAOYSA-N 2-[(8-amino-3-benzyl-6-bromoimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Br)C(=C(N=2)NCC(=O)NO)CC1=CC=CC=C1 VWMIHRBIXYAHLA-UHFFFAOYSA-N 0.000 description 1
- BPEKPZQXDQLVSZ-UHFFFAOYSA-N 2-[(8-amino-3-benzyl-6-chloroimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Cl)C(=C(N=2)NCC(=O)NO)CC1=CC=CC=C1 BPEKPZQXDQLVSZ-UHFFFAOYSA-N 0.000 description 1
- SDTKMYAMRTZMEA-UHFFFAOYSA-N 2-[(8-amino-3-butyl-6-chloroimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Cl)C(=C(N=2)NCC(=O)NO)CCCC SDTKMYAMRTZMEA-UHFFFAOYSA-N 0.000 description 1
- DGONHAZKILJTPU-UHFFFAOYSA-N 2-[(8-amino-3-butylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=CC=1)C(=C(N=2)NCC(=O)NO)CCCC DGONHAZKILJTPU-UHFFFAOYSA-N 0.000 description 1
- HNUQSPNQLCXMMG-UHFFFAOYSA-N 2-[(8-amino-3-tert-butyl-6-chloroimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Cl)C(=C(N=2)NCC(=O)NO)C(C)(C)C HNUQSPNQLCXMMG-UHFFFAOYSA-N 0.000 description 1
- UMTVUGISYJHTJN-UHFFFAOYSA-N 2-[(8-amino-6-bromo-3-cyclohexylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Br)C(=C(N=2)NCC(=O)NO)C1CCCCC1 UMTVUGISYJHTJN-UHFFFAOYSA-N 0.000 description 1
- WPLOKBDTNACPKQ-UHFFFAOYSA-N 2-[(8-amino-6-bromo-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound CCCCCc1c(NCC(=O)NO)nc2c(N)cc(Br)cn12 WPLOKBDTNACPKQ-UHFFFAOYSA-N 0.000 description 1
- LCNHQDFNUZUZAH-UHFFFAOYSA-N 2-[(8-amino-6-bromo-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound CCCc1c(NCC(=O)NO)nc2c(N)cc(Br)cn12 LCNHQDFNUZUZAH-UHFFFAOYSA-N 0.000 description 1
- RLBPYOJZGGZIJX-UHFFFAOYSA-N 2-[(8-amino-6-bromo-3-tert-butylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Br)C(=C(N=2)NCC(=O)NO)C(C)(C)C RLBPYOJZGGZIJX-UHFFFAOYSA-N 0.000 description 1
- PPXOYWXPYLLVDK-UHFFFAOYSA-N 2-[(8-amino-6-chloro-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound CCCCCc1c(NCC(=O)NO)nc2c(N)cc(Cl)cn12 PPXOYWXPYLLVDK-UHFFFAOYSA-N 0.000 description 1
- JMBATPANOGINOZ-UHFFFAOYSA-N 2-[(8-amino-6-chloro-3-propylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Cl)C(=C(N=2)NCC(=O)NO)CCC JMBATPANOGINOZ-UHFFFAOYSA-N 0.000 description 1
- VMBZRBSUYJBXRH-UHFFFAOYSA-N 2-[(8-bromo-6-chloro-3-cyclohexylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=2N(C=C(C=1)Cl)C(=C(N=2)NCC(=O)NO)C1CCCCC1 VMBZRBSUYJBXRH-UHFFFAOYSA-N 0.000 description 1
- QGAQCMCFKWOVEE-UHFFFAOYSA-N 2-[(8-bromo-6-methyl-3-pentylimidazo[1,2-a]pyridin-2-yl)amino]-N-hydroxyacetamide Chemical compound BrC=1C=2N(C=C(C=1)C)C(=C(N=2)NCC(=O)NO)CCCCC QGAQCMCFKWOVEE-UHFFFAOYSA-N 0.000 description 1
- VCNHXBWWCDYONL-UHFFFAOYSA-N 2-[[1-(2,2-dimethylpropyl)-9-hydroxyimidazo[1,2-a]quinolin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C1=C(C=CC=C1C=C2)O)NCC(=O)NO)(C)C VCNHXBWWCDYONL-UHFFFAOYSA-N 0.000 description 1
- URMVHKHCBCMWIH-UHFFFAOYSA-N 2-[[2-(hydroxyamino)-2-oxoethyl]amino]-3-(hydroxymethyl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound ONC(=O)CNC=1N=C2N(C=C(C=C2)C(=O)N)C1CO URMVHKHCBCMWIH-UHFFFAOYSA-N 0.000 description 1
- VUFOVAUFQAUXMU-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-5,7-dimethylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C(=CC(=C2)C)C)NCC(=O)NO)(C)C VUFOVAUFQAUXMU-UHFFFAOYSA-N 0.000 description 1
- PNFDUQHWYPUUFK-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-5-ethylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C(=CC=C2)CC)NCC(=O)NO)(C)C PNFDUQHWYPUUFK-UHFFFAOYSA-N 0.000 description 1
- SJAANFCOYAAZJJ-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-5-methyl-6-nitroimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C(=C(C=C2)[N+](=O)[O-])C)NCC(=O)NO)(C)C SJAANFCOYAAZJJ-UHFFFAOYSA-N 0.000 description 1
- TVTRLKFDJGJYQM-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-5-methylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C(=CC=C2)C)NCC(=O)NO)(C)C TVTRLKFDJGJYQM-UHFFFAOYSA-N 0.000 description 1
- CLZLCRYQTKJNEL-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-5-propylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C(=CC=C2)CCC)NCC(=O)NO)(C)C CLZLCRYQTKJNEL-UHFFFAOYSA-N 0.000 description 1
- UNRCNQQPPOWAFZ-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=C(C=C2)C(F)(F)F)NCC(=O)NO)(C)C UNRCNQQPPOWAFZ-UHFFFAOYSA-N 0.000 description 1
- MQYPWJDWSYMYHP-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-6-fluoroimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=C(C=C2)F)NCC(=O)NO)(C)C MQYPWJDWSYMYHP-UHFFFAOYSA-N 0.000 description 1
- SASJQQXFLYIBIY-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-6-methylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=C(C=C2)C)NCC(=O)NO)(C)C SASJQQXFLYIBIY-UHFFFAOYSA-N 0.000 description 1
- NNSAWKDKWBARLV-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-6-nitroimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=C(C=C2)[N+](=O)[O-])NCC(=O)NO)(C)C NNSAWKDKWBARLV-UHFFFAOYSA-N 0.000 description 1
- MZUNQPDWZUQXDN-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-7-methyl-6-nitroimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=C(C(=C2)C)[N+](=O)[O-])NCC(=O)NO)(C)C MZUNQPDWZUQXDN-UHFFFAOYSA-N 0.000 description 1
- VMPZWTMUWCDYPI-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-8-ethyl-5-methylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C(=CC=C2CC)C)NCC(=O)NO)(C)C VMPZWTMUWCDYPI-UHFFFAOYSA-N 0.000 description 1
- AHPPDWZAYRIENP-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-8-hydroxyimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=CC=C2O)NCC(=O)NO)(C)C AHPPDWZAYRIENP-UHFFFAOYSA-N 0.000 description 1
- BTQAHRBTFRMGLN-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-8-methylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(CC1=C(N=C2N1C=CC=C2C)NCC(=O)NO)(C)C BTQAHRBTFRMGLN-UHFFFAOYSA-N 0.000 description 1
- IBJAUHUEMRFVRX-UHFFFAOYSA-N 2-[[3-(2,2-dimethylpropyl)-8-phenylmethoxyimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)OC=1C=2N(C=CC=1)C(=C(N=2)NCC(=O)NO)CC(C)(C)C IBJAUHUEMRFVRX-UHFFFAOYSA-N 0.000 description 1
- KRGVUMHVWXIRNP-UHFFFAOYSA-N 2-[[3-benzyl-8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C1=CC=CC=C1)C1=C(N=C2N1C=C(C=C2Cl)C(F)(F)F)NCC(=O)NO KRGVUMHVWXIRNP-UHFFFAOYSA-N 0.000 description 1
- MQOFUALALDIRQC-UHFFFAOYSA-N 2-[[3-cyclohexyl-7-(hydroxymethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C1(CCCCC1)C1=C(N=C2N1C=CC(=C2)CO)NCC(=O)NO MQOFUALALDIRQC-UHFFFAOYSA-N 0.000 description 1
- YRUDRWZBKASYLH-UHFFFAOYSA-N 2-[[3-tert-butyl-7-(hydroxymethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C)(C)(C)C1=C(N=C2N1C=CC(=C2)CO)NCC(=O)NO YRUDRWZBKASYLH-UHFFFAOYSA-N 0.000 description 1
- BWFZWDPIAQBZOW-UHFFFAOYSA-N 2-[[5,7-dimethyl-3-(2-methylsulfanylethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC1=CC(=CC=2N1C(=C(N2)NCC(=O)NO)CCSC)C BWFZWDPIAQBZOW-UHFFFAOYSA-N 0.000 description 1
- BDSOHNMWYOFTDP-UHFFFAOYSA-N 2-[[5-amino-3-(2,2,2-trifluoroethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CC(F)(F)F BDSOHNMWYOFTDP-UHFFFAOYSA-N 0.000 description 1
- CCSGHPDNHJEBSC-UHFFFAOYSA-N 2-[[5-amino-3-(3,3,3-trifluoropropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCC(F)(F)F CCSGHPDNHJEBSC-UHFFFAOYSA-N 0.000 description 1
- UXPIWQCPDVSOMC-UHFFFAOYSA-N 2-[[5-bromo-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CC(C)(C)C UXPIWQCPDVSOMC-UHFFFAOYSA-N 0.000 description 1
- CHQPDNAEHYJGNT-UHFFFAOYSA-N 2-[[5-bromo-3-(2-methylsulfanylethyl)imidazo[1,2-b]isoquinolin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1N2C(C=C3C=CC=CC=13)=NC(=C2CCSC)NCC(=O)NO CHQPDNAEHYJGNT-UHFFFAOYSA-N 0.000 description 1
- YXMMOMKFLQIABX-UHFFFAOYSA-N 2-[[5-chloro-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound ClC1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CC(C)(C)C YXMMOMKFLQIABX-UHFFFAOYSA-N 0.000 description 1
- DQCLEUDCEXORPW-UHFFFAOYSA-N 2-[[5-ethyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CC(C)C DQCLEUDCEXORPW-UHFFFAOYSA-N 0.000 description 1
- XOIPOEVQZXUFOY-UHFFFAOYSA-N 2-[[5-ethyl-3-(2-methylsulfanylethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=CC=2N1C(=C(N=2)NCC(=O)NO)CCSC XOIPOEVQZXUFOY-UHFFFAOYSA-N 0.000 description 1
- IPJGOAPLCSCNQP-UHFFFAOYSA-N 2-[[6,8-dibromo-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)(C)C)Br IPJGOAPLCSCNQP-UHFFFAOYSA-N 0.000 description 1
- JSOUDOMDCGSKTJ-UHFFFAOYSA-N 2-[[6,8-dibromo-3-(2-methylsulfanylethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CCSC)Br JSOUDOMDCGSKTJ-UHFFFAOYSA-N 0.000 description 1
- DYSOXYFTEXCJNY-UHFFFAOYSA-N 2-[[6,8-dibromo-3-(hydroxymethyl)-5-methylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C1C)C(=C(N2)NCC(=O)NO)CO)Br DYSOXYFTEXCJNY-UHFFFAOYSA-N 0.000 description 1
- RZQZSEKYFVLESX-UHFFFAOYSA-N 2-[[6,8-dibromo-3-(hydroxymethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CO)Br RZQZSEKYFVLESX-UHFFFAOYSA-N 0.000 description 1
- SHUITBBWNRPMAO-UHFFFAOYSA-N 2-[[6,8-dibromo-5-methyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1C)C(=C(N=2)NCC(=O)NO)CC(C)C)Br SHUITBBWNRPMAO-UHFFFAOYSA-N 0.000 description 1
- PMSMVZIZRYTEDJ-UHFFFAOYSA-N 2-[[6,8-dichloro-3-(hydroxymethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound ClC=1C=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CO)Cl PMSMVZIZRYTEDJ-UHFFFAOYSA-N 0.000 description 1
- HYEUWFQAMPBVIW-UHFFFAOYSA-N 2-[[6,8-difluoro-3-(2-methylsulfanylethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound FC=1C=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CCSC)F HYEUWFQAMPBVIW-UHFFFAOYSA-N 0.000 description 1
- WERZDKOFUDWKQN-UHFFFAOYSA-N 2-[[6-amino-3-(2,2,2-trifluoroethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(F)(F)F WERZDKOFUDWKQN-UHFFFAOYSA-N 0.000 description 1
- DUKOSZDIYUKAPK-UHFFFAOYSA-N 2-[[6-amino-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)(C)C DUKOSZDIYUKAPK-UHFFFAOYSA-N 0.000 description 1
- KUQVTYNITLYGCT-UHFFFAOYSA-N 2-[[6-amino-3-(3,3,3-trifluoropropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CCC(F)(F)F KUQVTYNITLYGCT-UHFFFAOYSA-N 0.000 description 1
- JPPKHTPPODJUBF-UHFFFAOYSA-N 2-[[6-bromo-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)(C)C JPPKHTPPODJUBF-UHFFFAOYSA-N 0.000 description 1
- OQLQHGHLFZOLGZ-UHFFFAOYSA-N 2-[[6-bromo-5-methyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound CC(C)Cc1c(NCC(=O)NO)nc2ccc(Br)c(C)n12 OQLQHGHLFZOLGZ-UHFFFAOYSA-N 0.000 description 1
- JYYVVDBQRHCFHY-UHFFFAOYSA-N 2-[[6-bromo-5-methyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxypropanamide Chemical compound CC(C)Cc1c(NC(C)C(=O)NO)nc2ccc(Br)c(C)n12 JYYVVDBQRHCFHY-UHFFFAOYSA-N 0.000 description 1
- BALPWRAMGVDSAC-ONEGZZNKSA-N 2-[[6-bromo-5-methyl-3-[(E)-prop-1-enyl]imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=CC=2N(C=1C)C(=C(N=2)NCC(=O)NO)\C=C\C BALPWRAMGVDSAC-ONEGZZNKSA-N 0.000 description 1
- CFHPPJJNXAQHJH-UHFFFAOYSA-N 2-[[6-bromo-7,8-dimethyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C(=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)C)C)C CFHPPJJNXAQHJH-UHFFFAOYSA-N 0.000 description 1
- XWIOZPSSMOUORS-UHFFFAOYSA-N 2-[[6-bromo-7-methyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C(=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)C)C XWIOZPSSMOUORS-UHFFFAOYSA-N 0.000 description 1
- CWDDEBOCBRNOQA-UHFFFAOYSA-N 2-[[6-bromo-8-methyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound BrC=1C=C(C=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)C)C CWDDEBOCBRNOQA-UHFFFAOYSA-N 0.000 description 1
- MSWZXTDYPHYFRO-UHFFFAOYSA-N 2-[[6-bromo-8-methyl-3-(2-methylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxypropanamide Chemical compound BrC=1C=C(C=2N(C=1)C(=C(N=2)NC(C(=O)NO)C)CC(C)C)C MSWZXTDYPHYFRO-UHFFFAOYSA-N 0.000 description 1
- TYGZDORIDXDQPW-UHFFFAOYSA-N 2-[[6-chloro-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound ClC=1C=CC=2N(C=1)C(=C(N=2)NCC(=O)NO)CC(C)(C)C TYGZDORIDXDQPW-UHFFFAOYSA-N 0.000 description 1
- CLMOSSQVWHJOBE-UHFFFAOYSA-N 2-[[7-ethyl-3-(1H-imidazol-2-yl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C)C1=CC=2N(C=C1)C(=C(N=2)NCC(=O)NO)C=1NC=CN=1 CLMOSSQVWHJOBE-UHFFFAOYSA-N 0.000 description 1
- PJVHYFHBHZRBPI-UHFFFAOYSA-N 2-[[8-amino-3-(2,2-dimethylpropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=CC=1)C(=C(N=2)NCC(=O)NO)CC(C)(C)C PJVHYFHBHZRBPI-UHFFFAOYSA-N 0.000 description 1
- PUVXUPBJFPFWFY-UHFFFAOYSA-N 2-[[8-amino-3-(3,3,3-trifluoropropyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=CC=1)C(=C(N=2)NCC(=O)NO)CCC(F)(F)F PUVXUPBJFPFWFY-UHFFFAOYSA-N 0.000 description 1
- GIHKKZDKUMJQAS-UHFFFAOYSA-N 2-[[8-amino-6-bromo-3-(hydroxymethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Br)C(=C(N=2)NCC(=O)NO)CO GIHKKZDKUMJQAS-UHFFFAOYSA-N 0.000 description 1
- WVITVBHUKBJORE-UHFFFAOYSA-N 2-[[8-amino-6-chloro-3-(hydroxymethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound NC=1C=2N(C=C(C=1)Cl)C(=C(N=2)NCC(=O)NO)CO WVITVBHUKBJORE-UHFFFAOYSA-N 0.000 description 1
- FHIBTGFOQRAMQF-UHFFFAOYSA-N 2-[[8-chloro-3-pentyl-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound ClC=1C=2N(C=C(C=1)C(F)(F)F)C(=C(N=2)NCC(=O)NO)CCCCC FHIBTGFOQRAMQF-UHFFFAOYSA-N 0.000 description 1
- JNSPPZQWBRVYCU-UHFFFAOYSA-N 2-[[8-ethyl-3-(hydroxymethyl)-5-methylimidazo[1,2-a]pyridin-2-yl]amino]-N-hydroxyacetamide Chemical compound C(C)C=1C=2N(C(=CC=1)C)C(=C(N=2)NCC(=O)NO)CO JNSPPZQWBRVYCU-UHFFFAOYSA-N 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- XJPOIBQKCZRJKT-UHFFFAOYSA-N 3-(2,2-dimethylpropyl)-2-[[2-(hydroxyamino)-2-oxoethyl]amino]imidazo[1,2-a]pyridine-8-carboxylic acid Chemical compound CC(CC1=C(N=C2N1C=CC=C2C(=O)O)NCC(NO)=O)(C)C XJPOIBQKCZRJKT-UHFFFAOYSA-N 0.000 description 1
- ZOBARGSEHDWMLS-UHFFFAOYSA-N 3-[8-amino-6-chloro-2-[[2-(hydroxyamino)-2-oxoethyl]amino]imidazo[1,2-a]pyridin-3-yl]propanoic acid Chemical compound NC=1C=2N(C=C(C1)Cl)C(=C(N2)NCC(NO)=O)CCC(=O)O ZOBARGSEHDWMLS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical group CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- AIMDCLGMBKTVPK-UHFFFAOYSA-N CC(CC1=C(N=C2N1C1=CC=CC=C1C(=C2)O)NCC(=O)NO)(C)C Chemical compound CC(CC1=C(N=C2N1C1=CC=CC=C1C(=C2)O)NCC(=O)NO)(C)C AIMDCLGMBKTVPK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- PJVOSOBAENFKSO-UHFFFAOYSA-N N-hydroxy-2-[(7-methylimidazo[1,2-a]pyridin-2-yl)amino]-3-phenylpropanamide Chemical compound ONC(C(CC1=CC=CC=C1)NC=1N=C2N(C=CC(=C2)C)C1)=O PJVOSOBAENFKSO-UHFFFAOYSA-N 0.000 description 1
- JIXOUYJPCXIYGI-UHFFFAOYSA-N N-hydroxy-2-[(8-hydroxy-3-methylimidazo[1,2-a]pyridin-2-yl)amino]-3-phenylpropanamide Chemical compound ONC(C(CC1=CC=CC=C1)NC=1N=C2N(C=CC=C2O)C=1C)=O JIXOUYJPCXIYGI-UHFFFAOYSA-N 0.000 description 1
- OYVVWUBLCKLAMS-UHFFFAOYSA-N N-hydroxy-2-[[3-(hydroxymethyl)-8-phenylmethoxyimidazo[1,2-a]pyridin-2-yl]amino]acetamide Chemical compound C(C1=CC=CC=C1)OC=1C=2N(C=CC=1)C(=C(N=2)NCC(=O)NO)CO OYVVWUBLCKLAMS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000005354 acylalkyl group Chemical group 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- HSMPSHPWCOOUJH-UHFFFAOYSA-N anilinyl Chemical group [NH]C1=CC=CC=C1 HSMPSHPWCOOUJH-UHFFFAOYSA-N 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000005018 aryl alkenyl group Chemical group 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 125000005015 aryl alkynyl group Chemical group 0.000 description 1
- 125000004350 aryl cycloalkyl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- 150000003997 cyclic ketones Chemical class 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohex-2-enone Chemical compound O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 1
- 125000003678 cyclohexadienyl group Chemical group C1(=CC=CCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 125000004475 heteroaralkyl group Chemical group 0.000 description 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- PWWXIULQEXRUCV-UHFFFAOYSA-N imidazo[1,2-a]pyridine-6-carboxamide Chemical compound C1=C(C(=O)N)C=CC2=NC=CN21 PWWXIULQEXRUCV-UHFFFAOYSA-N 0.000 description 1
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 1
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- JIQNWFBLYKVZFY-UHFFFAOYSA-N methoxycyclohexatriene Chemical compound COC1=C[C]=CC=C1 JIQNWFBLYKVZFY-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical group 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005019180.0 | 2005-04-25 | ||
| DE102005019180 | 2005-04-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2007143501A RU2007143501A (ru) | 2009-06-10 |
| RU2409575C2 true RU2409575C2 (ru) | 2011-01-20 |
Family
ID=36686088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007143501/04A RU2409575C2 (ru) | 2005-04-25 | 2006-04-24 | ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ, КОТОРЫЕ МОЖНО ИСПОЛЬЗОВАТЬ В КАЧЕСТВЕ ИНГИБИТОРОВ ПЕПТИДДЕФОРМИЛАЗЫ (ПДФ) |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1877407A1 (enExample) |
| JP (1) | JP2008538776A (enExample) |
| KR (1) | KR20080002866A (enExample) |
| CN (1) | CN101166740B (enExample) |
| AU (1) | AU2006239546B2 (enExample) |
| BR (1) | BRPI0610842A2 (enExample) |
| CA (1) | CA2606251A1 (enExample) |
| MX (1) | MX2007013237A (enExample) |
| RU (1) | RU2409575C2 (enExample) |
| WO (1) | WO2006114261A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563797B2 (en) | 2006-08-28 | 2009-07-21 | Forest Laboratories Holding Limited | Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| JP4986249B2 (ja) * | 2006-10-06 | 2012-07-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | チマーゼ阻害剤 |
| KR20190084991A (ko) * | 2016-11-28 | 2019-07-17 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 피라졸로-헤테로아릴 유도체, 이의 제조 방법 및 의학적 용도 |
| CN107245050B (zh) * | 2016-12-05 | 2019-10-25 | 徐州医科大学 | 香草醛异羟肟酸类衍生物及其应用 |
| US11744824B2 (en) | 2020-09-15 | 2023-09-05 | 1ST Biotherapeutics, Inc. | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU852173A3 (ru) * | 1977-05-18 | 1981-07-30 | Хиноин Дьедьсер Еш Ведьесетитермекек Дьяра Pt (Инопредприятие) | Способ получени производных дигидРОиМидАзО изОХиНО-лиНА или иХ СОлЕй |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0717971A (ja) * | 1993-07-02 | 1995-01-20 | Takeda Chem Ind Ltd | イミダゾール誘導体、その製造法及び用途 |
| CZ297278B6 (cs) * | 1996-08-07 | 2006-10-11 | Darwin Discovery Limited | Deriváty hydroxamové a karboxylové kyseliny a jejich pouzití |
| AR029916A1 (es) * | 2000-05-05 | 2003-07-23 | Smithkline Beecham Corp | N-formil-n-hidroxi-ariloxi alquilaminas y metodos para tratar infecciones bacterianas |
| UY27813A1 (es) * | 2002-05-31 | 2003-12-31 | Smithkline Beecham Corp | Inhibidores de la peptido-desformilasa |
| US7442793B2 (en) * | 2002-12-11 | 2008-10-28 | Smithkline Beecham Corporation | Peptide deformylase inhibitors |
-
2006
- 2006-04-24 KR KR1020077024436A patent/KR20080002866A/ko not_active Ceased
- 2006-04-24 WO PCT/EP2006/003765 patent/WO2006114261A1/en not_active Ceased
- 2006-04-24 CA CA002606251A patent/CA2606251A1/en not_active Abandoned
- 2006-04-24 RU RU2007143501/04A patent/RU2409575C2/ru not_active IP Right Cessation
- 2006-04-24 CN CN2006800140369A patent/CN101166740B/zh not_active Expired - Fee Related
- 2006-04-24 MX MX2007013237A patent/MX2007013237A/es not_active Application Discontinuation
- 2006-04-24 JP JP2008508132A patent/JP2008538776A/ja active Pending
- 2006-04-24 EP EP06742662A patent/EP1877407A1/en not_active Withdrawn
- 2006-04-24 AU AU2006239546A patent/AU2006239546B2/en not_active Ceased
- 2006-04-24 BR BRPI0610842-3A patent/BRPI0610842A2/pt not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU852173A3 (ru) * | 1977-05-18 | 1981-07-30 | Хиноин Дьедьсер Еш Ведьесетитермекек Дьяра Pt (Инопредприятие) | Способ получени производных дигидРОиМидАзО изОХиНО-лиНА или иХ СОлЕй |
Non-Patent Citations (1)
| Title |
|---|
| E.Winkelmann et al. Chemotherapeutisch wirksame Nitroverbindungen. 3. Mitteilung: Nitropyridine, Nitroimidazopyridine und verwandte Verbindungen, Arzneimittel forschung / Drug research, 27 (1), 1977, ss.82-89. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101166740A (zh) | 2008-04-23 |
| EP1877407A1 (en) | 2008-01-16 |
| WO2006114261A1 (en) | 2006-11-02 |
| JP2008538776A (ja) | 2008-11-06 |
| KR20080002866A (ko) | 2008-01-04 |
| AU2006239546A1 (en) | 2006-11-02 |
| CN101166740B (zh) | 2010-12-29 |
| CA2606251A1 (en) | 2006-11-02 |
| RU2007143501A (ru) | 2009-06-10 |
| MX2007013237A (es) | 2008-01-24 |
| BRPI0610842A2 (pt) | 2010-07-27 |
| AU2006239546B2 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2069020B1 (en) | Benzo[d]isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine | |
| US8163742B2 (en) | Di-amino-substituted heterocyclic compounds and methods of use | |
| RU2420526C2 (ru) | ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ, КОТОРЫЕ МОЖНО ИСПОЛЬЗОВАТЬ В КАЧЕСТВЕ ИНГИБИТОРОВ ПЕПТИДДЕФОРМИЛАЗЫ (ПДФ) | |
| BR112017003054B1 (pt) | Compostos de aminopirimidinila e composição farmacêutica ou veterinária | |
| WO2003001887A2 (en) | Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors | |
| JP7339263B2 (ja) | Ｊａｋ阻害剤としてのピラゾロピリミジン化合物 | |
| CA3035712A1 (en) | 8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereof | |
| CN101166740B (zh) | 用作肽脱甲酰基酶(pdf)抑制剂的咪唑并[1,2-a]吡啶衍生物 | |
| JP2008542410A (ja) | リパーゼ及びホスホリパーゼ阻害剤としてのアゾロピリジン−２−オン誘導体 | |
| JP2008542411A (ja) | リパーゼ及びホスホリパーゼ阻害剤としてのベンゾチアゾール−２−オン誘導体 | |
| AU2007272830B2 (en) | Alkyne-substituted pyridone compounds and methods of use | |
| BRPI0611694A2 (pt) | inibidores peptìdicos da deformilase 4 (pdf) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20120425 |